Emkay Global shareholders approve all seven resolutions at 32nd AGM

2 min read     Updated on 12 Aug 2026, 08:50 PM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Emkay Global Financial Services shareholders unanimously approved all seven resolutions at its 32nd AGM on August 10, 2026. The approvals cover the adoption of FY26 financial statements, dividend declaration, and strategic moves including increased borrowing limits and NCD issuance. Promoter and institutional investors backed all proposals, with minimal dissent from public shareholders.

powered bylight_fuzz_icon
48093631

*this image is generated using AI for illustrative purposes only.

Emkay Global Financial Services shareholders approved all seven resolutions proposed at its 32nd Annual General Meeting (AGM) held on August 10, 2026. The meeting, conducted via video conferencing and other audio-visual means, concluded with unanimous support for key corporate governance and financial matters, including the adoption of audited financial statements for the fiscal year ended March 31, 2026.

The company reported a total of 12,103 shareholders as on the cut-off date of August 3, 2026. Participation was primarily digital, with 130 shareholders attending through video conferencing—comprising five from the promoter group and 125 from the public category. No shareholders were present in person or through proxy.

Voting Results Overview

All resolutions passed with overwhelming support. The promoter group, holding 20,053,984 shares, cast votes in favor of every resolution without any dissenting votes. Institutional investors, holding 207,979 shares, also voted unanimously in favor. Among non-institutional public shareholders, who hold 7,363,617 shares, voting participation was lower but support remained near-universal, with only two to three votes cast against specific resolutions.

Resolution Description Type Votes In Favor Votes Against Status
Adoption of Audited Standalone Financial Statements (FY26) Ordinary 20,273,469 2 Passed
Adoption of Audited Consolidated Financial Statements (FY26) Ordinary 20,273,469 2 Passed
Declaration of Dividend on Equity Shares (FY26) Ordinary 20,273,469 2 Passed
Re-appointment of S. K. Saboo as Director Special 20,273,469 2 Passed
Payment of Commission to Independent Directors (FY27-FY31) Special 20,273,468 3 Passed
Increase in Borrowing Limits and Creation of Charge Special 20,273,469 2 Passed
Issuance of Non-Convertible Debentures via Private Placement Special 20,273,468 3 Passed

Key Corporate Actions

The approval of the special resolution regarding the increase in borrowing limits and creation of charge on assets signals the company’s intent to expand its leverage capacity, potentially to fund growth initiatives or manage liquidity requirements. Similarly, the authorization for the issuance of non-convertible debentures (NCDs) on a private placement basis provides Emkay Global with a flexible avenue to raise debt capital from select investors.

The board also secured shareholder consent for the payment of commissions to independent directors for a five-year period spanning from FY27 to FY31. This resolution aims to ensure competitive remuneration for board oversight during this tenure. Additionally, Mr. S. K. Saboo (DIN: 00373201), who retired by rotation, was successfully reappointed as a director, maintaining continuity in the company’s leadership structure.

Scrutinizer’s Report

Parikh & Associates, acting as the scrutinizer, confirmed that the e-voting process complied with Section 108 of the Companies Act, 2013, and Rule 20 of the Companies (Management and Administration) Rules, 2014. The remote e-voting period ran from August 7 to August 9, 2026, facilitated by Central Depository Services (India) Limited (CDSL). No invalid votes were recorded across any of the resolutions.

Historical Stock Returns for Emkay Global Financial Services

1 Day5 Days1 Month6 Months1 Year5 Years
+3.29%-0.08%-6.76%-2.47%+12.28%+112.34%

How will the approved increase in borrowing limits and creation of charges impact Emkay Global's debt-to-equity ratio and credit rating in the near term?

What specific growth initiatives or liquidity needs is the company targeting with the authorized issuance of non-convertible debentures via private placement?

Given the unanimous support for dividend declaration, does this signal a shift in capital allocation strategy towards shareholder returns versus reinvestment in FY27?

Emkay Global Financial Services
View Company Insights
View All News
like16
dislike

Emkay Global's Dr. Satish Ugrankar exits board after completing second term

1 min read     Updated on 09 Aug 2026, 08:17 PM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Emkay Global Financial Services announced that Dr. Satish Ugrankar has stepped down as an Independent Director effective August 9, 2026, upon completing his maximum permissible second term. He vacates all committee memberships, including Chairperson of the Stakeholder's Relationship Committee.

powered bylight_fuzz_icon
47825839

*this image is generated using AI for illustrative purposes only.

Emkay Global Financial Services announced that Dr. Satish Ugrankar has ceased to be a member of its Board of Directors effective August 9, 2026. The departure marks the conclusion of his second consecutive five-year tenure as an Independent Director, a limit imposed by regulatory guidelines to ensure board refreshment. This change affects the composition of several key board committees, requiring the company to appoint replacements to maintain compliance with SEBI listing regulations.

The exit was disclosed pursuant to Regulations 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Dr. Ugrankar’s DIN is 00043783. The Board of Directors expressed appreciation for his contributions during his tenure. In line with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, the company provided detailed disclosures regarding the change in directorship.

Committee Exits

Upon ceasing to be a director, Dr. Ugrankar automatically vacated his positions in all board committees. His roles included:

  • Chairperson of the Stakeholder's Relationship Committee
  • Member of the Audit Committee
  • Member of the Nomination, Remuneration and Compensation Committee

These vacancies must be filled by the Board to ensure continuous oversight in these critical governance areas.

What This Means for Governance

The completion of a second term for an Independent Director is a standard procedural event under Indian corporate law, designed to prevent entrenchment and bring fresh perspectives to the board. For investors, this signals a routine governance update rather than a strategic shift or conflict. The primary implication is the administrative task of identifying and appointing a new Independent Director who meets the eligibility criteria set by SEBI. Until a successor is appointed, the remaining Independent Directors will manage the committee responsibilities, though companies typically move quickly to fill such gaps to avoid any perception of non-compliance with quorum requirements for committee meetings.

Historical Stock Returns for Emkay Global Financial Services

1 Day5 Days1 Month6 Months1 Year5 Years
+3.29%-0.08%-6.76%-2.47%+12.28%+112.34%

What specific qualifications or industry expertise is Emkay Global prioritizing when searching for Dr. Ugrankar's successor to the Board?

How might the transition of the Stakeholder's Relationship Committee chairmanship impact the company's investor communication strategy in the short term?

Are there any pending regulatory filings or audit cycles that could be affected by the temporary vacancy in the Audit Committee before a new member is appointed?

Emkay Global Financial Services
View Company Insights
View All News
like19
dislike

More News on Emkay Global Financial Services

1 Year Returns:+12.28%